A detailed history of Ensign Peak Advisors, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 3,706,815 shares of MRK stock, worth $373 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
3,706,815
Previous 4,098,843 9.56%
Holding current value
$373 Million
Previous $507 Million 17.04%
% of portfolio
0.75%
Previous 0.94%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $43.6 Million - $50.6 Million
-392,028 Reduced 9.56%
3,706,815 $421 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $103 Million - $111 Million
-832,195 Reduced 16.88%
4,098,843 $507 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $18.6 Million - $21.7 Million
-164,159 Reduced 3.22%
4,931,038 $651 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $30.4 Million - $33.1 Million
-303,289 Reduced 5.62%
5,095,197 $555 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $12.7 Million - $14.1 Million
122,990 Added 2.33%
5,398,486 $556 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $13 Million - $14.1 Million
-119,276 Reduced 2.21%
5,275,496 $609 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $54.8 Million - $61.1 Million
532,288 Added 10.95%
5,394,772 $574 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $6.23 Million - $7.98 Million
71,207 Added 1.49%
4,862,484 $539 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $39.7 Million - $44.6 Million
469,758 Added 10.87%
4,791,277 $413 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $197 Million - $224 Million
2,362,744 Added 120.62%
4,321,519 $394 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $39.2 Million - $43.9 Million
532,676 Added 37.35%
1,958,775 $161 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $95.1 Million - $119 Million
-1,315,527 Reduced 47.98%
1,426,099 $109 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $15 Million - $16.4 Million
-208,676 Reduced 7.07%
2,741,626 $206 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $37.3 Million - $41.2 Million
-530,181 Reduced 15.23%
2,950,302 $229 Million
Q1 2021

May 12, 2021

SELL
$68.86 - $81.11 $29.7 Million - $35 Million
-431,732 Reduced 11.04%
3,480,483 $268 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $16.3 Million - $18 Million
-226,597 Reduced 5.47%
3,912,215 $320 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $40.2 Million - $45.5 Million
-548,961 Reduced 11.71%
4,138,812 $343 Million
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $35 Million - $39.9 Million
-497,663 Reduced 9.6%
4,687,773 $363 Million
Q1 2020

May 11, 2020

BUY
$63.36 - $87.82 $36.7 Million - $50.8 Million
578,924 Added 12.57%
5,185,436 $399 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $357 Million - $403 Million
4,606,512 New
4,606,512 $419 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $255B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.